Sapanisertib, Carboplatin, and Paclitaxel in Treating Patients With Recurrent or Refractory Malignant Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Carboplatin
Related studies linked through entity extraction aliases.
AZD9150 Plus Durvalumab Alone or in Combination With Chemotherapy in Patients With Advanced, Solid Tumours and in Patients With Non-Small-Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Individualized Adaptive De-escalated Radiotherapy for HPV-related Oropharynx Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Carboplatin +/- Nivolumab in Metastatic Triple Negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pembrolizumab With Chemotherapy in Front Line Advanced Ovarian, Primary Peritoneal and Fallopian Tube Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
The EPIC Trial The Elderly Patient Individualized Chemotherapy Trial
- Status
- UNKNOWN
- Phase
- PHASE3
A Study Evaluating the Bioavailability and Food Effect of Veliparib Tablets Followed by an Extension in Subjects With Ovarian Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Study of Boserolimab (MK-5890) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Adults With Advanced Solid Tumors (MK-5890-001)
- Status
- COMPLETED
- Phase
- PHASE1
Atezolizumab With Neoadjuvant Chemotherapy for Patients With Newly-Diagnosed Advanced-Stage Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer (OVATION 2)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Trial to Compare the Efficacy, Safety, Pharmacokinetics and Immunogenicity of HD204 to Avastin® in Advanced Non-squamous Non-small Cell Lung Cancer Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
An Immuno-therapy Study of Nivolumab in Combination With Experimental Medication BMS-986205 Compared to Standard of Care EXTREME Regimen in First-line Recurrent/Metastatic Squamous Cell Carcinoma of Head and Neck
- Status
- WITHDRAWN
- Phase
- PHASE3
Prostate Cancer Biomarker Enrichment and Treatment Selection
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Cisplatin/Carboplatin and Etoposide With or Without Nivolumab in Treating Patients With Extensive Stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Personal Cancer Vaccine (NEO-PV-01) With Pembrolizumab and Chemotherapy for Patients With Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Combination Pembrolizumab, Chemotherapy and Bevacizumab in Patients With Cervical Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Lenalidomide Plus ICE in the Treatment of Refractory and Relapsed DLBCL
- Status
- UNKNOWN
- Phase
- PHASE2
Pembrolizumab Plus Epacadostat, Pembrolizumab Monotherapy, and the EXTREME Regimen in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-669/ECHO-304)
- Status
- COMPLETED
- Phase
- PHASE3